Literature DB >> 28161808

Does applying resolution recovery to normal databases confer an advantage over conventional 3D-stereotactic surface projection techniques?

Nobuhiro Yada1,2, Hideo Onishi3, Masahiro Miyai4, Kentarou Ozasa4, Takashi Katsube5, Keiichi Onoda6, Masuo Haramoto4, Yasushi Yamamoto4, Shuhei Yamaguchi6, Hajime Kitagaki5.   

Abstract

We evaluated a novel normal database (NDB) generated using single photon emission computed tomography (SPECT) data obtained from healthy brains by using a SPECT/CT system, analyzed using a resolution recovery (RR) technique applied to the three-dimensional stereotactic surface projection (3D-SSP) technique. We used a three-dimensional ordered subset expectation maximization method (3D-OSEM) with applied scatter correction (SC), attenuation correction, and RR to reconstruct the data. We verified the accuracy of the novel NDB's values (Z, extent, and error scores), and compared the novel NDB to the 3D-SSP technique by using simulated misery perfusion-related patient data from a conventional NDB. In addition, Z, extent, and error scores at the precuneus, cuneus, and posterior cingulate were compared under different reconstruction conditions by using the patient data. In the simulation, Z scores decreased when using the novel NDB corrected using computed tomography-based attenuation correction (CTAC), SC, and RR. The extent scores of the posterior cingulate increased using the novel NDB, relative to the other NDBs. The error score with the novel NDB without RR decreased by 15% compared to that of the conventional NDB. Z scores generated from patient data decreased in the novel NDB with RR. The extent scores tended to decrease in the novel NDB with RR. The extent scores in the novel NDB with RR improved at the posterior cingulate, compared to the scores with the other NDBs. However, applying RR to the novel NDB conferred no advantage because the cut-off of the current Z score must be reconsidered when using the additive RR technique.

Entities:  

Keywords:  Brain perfusion; Normal database (NDB); Resolution recovery; Single photon emission tomography (SPECT); Three-dimensional stereotactic surface projection (3D-SSP)

Mesh:

Year:  2017        PMID: 28161808     DOI: 10.1007/s12194-017-0391-8

Source DB:  PubMed          Journal:  Radiol Phys Technol        ISSN: 1865-0333


  32 in total

1.  Comparison of methods of attenuation and scatter correction in brain perfusion SPECT.

Authors:  Masuo Hayashi; Jun Deguchi; Keita Utsunomiya; Makoto Yamada; Tsuyoshi Komori; Masayasu Takeuchi; Kensei Kanna; Isamu Narabayashi
Journal:  J Nucl Med Technol       Date:  2005-12

2.  Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.

Authors:  Haruo Hanyu; Soichiro Shimizu; Kentaro Hirao; Hidekazu Kanetaka; Toshihiko Iwamoto; Taishiro Chikamori; Yasuhiro Usui; Akira Yamashina; Kiyoshi Koizumi; Kimihiko Abe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-11-22       Impact factor: 9.236

3.  Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.

Authors:  Yoshitaka Inui; Hiroshi Toyama; Yuta Manabe; Masayoshi Sarai; Nakao Iwata
Journal:  Ann Nucl Med       Date:  2014-07-02       Impact factor: 2.668

4.  Quantitative CBF measurement using an integrated SPECT/CT system: validation of three-dimensional ordered-subset expectation maximization and CT-based attenuation correction by comparing with O-15 water PET.

Authors:  Eku Shimosegawa; Kouichi Fujino; Hiroki Kato; Jun Hatazawa
Journal:  Ann Nucl Med       Date:  2013-07-04       Impact factor: 2.668

5.  Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography.

Authors:  T Imamura; K Ishii; M Sasaki; H Kitagaki; S Yamaji; N Hirono; T Shimomura; M Hashimoto; S Tanimukai; H Kazui; E Mori
Journal:  Neurosci Lett       Date:  1997-10-10       Impact factor: 3.046

6.  Regional cerebral blood flow in healthy volunteers measured by the graph plot method with iodoamphetamine SPECT.

Authors:  Kazunari Ishii; Takafumi Uemura; Naokazu Miyamoto; Toshiki Yoshikawa; Toshiaki Yamaguchi; Tatsuhiko Ashihara; Yukihiro Ohtani
Journal:  Ann Nucl Med       Date:  2010-12-10       Impact factor: 2.668

7.  Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.

Authors:  D Kogure; H Matsuda; T Ohnishi; T Asada; M Uno; T Kunihiro; S Nakano; M Takasaki
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

8.  Measurement of cerebral blood flow using graph plot analysis and I-123 iodoamphetamine.

Authors:  Kunio Okamoto; Yo Ushijima; Chio Okuyama; Tomoki Nakamura; Tsunehiko Nishimura
Journal:  Clin Nucl Med       Date:  2002-03       Impact factor: 7.794

9.  A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.

Authors:  Sean J Colloby; John D Fenwick; E David Williams; Sean M Paling; Kyriakos Lobotesis; Clive Ballard; Ian McKeith; John T O'Brien
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-05       Impact factor: 9.236

10.  Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography.

Authors:  H Matsuda; S Mizumura; T Nagao; T Ota; T Iizuka; K Nemoto; N Takemura; H Arai; A Homma
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.